Infertility News and Research

RSS

Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

For women seeking pregnancy by assisted reproductive technologies, such as in-vitro fertilization, a new study shows that the health of the uterus is more relevant than egg quality for a newborn to achieve normal birth weight and full gestation.

2 Feb 2011

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

New data shows Shady Grove Fertility Center's financial programs -- designed to help make infertility testing and treatment more affordable -- helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.

29 Jan 2011

First Edition: January 25, 2011

Today's health policy headlines include speculation about what President Barack Obama will say during tonight's State of The Union address and how the GOP will respond to it.

25 Jan 2011

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.

21 Jan 2011

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.

19 Jan 2011

Lifetime tool for families created through sperm donation

Starting a family the "old-fashioned way" is becoming less common. Only 25% of American households are made up of a husband, wife, and a child. The fertility field is continually growing with advances in scientific technology, and infertile patients have more options for conceiving -- including the use of donor sperm. Along with the medical advances comes the continual need for emotional support for both the parent and children.

14 Jan 2011

Vitrolife receives patent protection for Swemed Sense needle in European markets

Swemed Sense™ is a unique needle that is used for the collection of oocytes in connection with IVF. The approved patent means that Vitrolife has both design protection and product patent protection for Swemed Sense™ in strategically important European markets. A patent has also been applied for in other prioritized markets.

14 Jan 2011

Living at higher altitudes may increase risk for suicide

Twenty years of mortality data from counties across the United States led to the striking discovery that living at higher altitudes may be a risk factor for suicide, according to a provocative study published online ahead of print in High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is attached.

14 Jan 2011

BPA more harmful to women with hormonal and fertility imbalances

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), found higher Bisphenol A (BPA) levels in women with polycystic ovary syndrome (PCOS) compared to controls. Furthermore, researchers found a statistically significant positive association between male sex hormones and BPA in these women suggesting a potential role of BPA in ovarian dysfunction.

13 Jan 2011

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization will lead to a successful pregnancy.

13 Jan 2011

CE mark approves Vitrolife's SpermFreeze Solution

SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.

12 Jan 2011

How chlamydia increases risk of ectopic pregnancy

Women who have had chlamydia are at greater risk of an ectopic pregnancy because of a lasting effect of the infection.

11 Jan 2011

Proposed health research agency for UK

According to the Academy of Medical Sciences, a new body to regulate all health research in the UK should be established. The authorities suggest that the current regulatory system was dysfunctional and thus hampering medical advances and they blame red tape for the decline in the UK’s share of clinical research. The report suggests creating a Health Research Agency that would make approving projects quicker and cheaper. According to Health Secretary for England, Andrew Lansley, the government would consider how the recommendations could be implemented.

11 Jan 2011

Shady Grove Fertility and Cade Foundation grant help paralyzed patient and wife deliver healthy baby boy

Shady Grove Fertility Center is pleased to announce the birth of Collin James Sharp, born December 8, 2010 to Jennifer and David Sharp of Richmond, VA. The 7 lb. 15 oz baby boy's birth was made possible through a partnership of Shady Grove Fertility and the Cade Foundation.

11 Jan 2011

Researchers identify gene mutation for that is essential for correct protein-processing in cells

A Jackson Laboratory research team led by Professor Patsy Nishina, Ph.D., has identified a mutation in a gene that's essential for correct protein-processing in cells. Defects in protein folding are associated with a variety of abnormalities and diseases.

10 Jan 2011

Hologic announces acquisition of Interlace Medical

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired Interlace Medical, Inc. (Interlace), the developer and manufacturer of the MyoSure hysteroscopic tissue removal system (MyoSure). Interlace's operations will be integrated within Hologic's GYN Surgical Products division.

From Hologic, Inc. 7 Jan 2011

Study compares treatment cost of PID hospitalizations, ER care for teen girls

Hospitalizing teen girls with pelvic inflammatory disease costs six times as much as treating them in the emergency room, and up to 12 times more than treating them in an outpatient clinic, according to a small study conducted at the Johns Hopkins Children's Center.

6 Jan 2011

The Surrogacy Lawyer discusses role of yoga in helping women cope with infertility

Most of the public knows her as the suffering Mary Alice Young who speaks to the audience from the afterlife as the narrator of ABC's hit Desperate Housewives. But they may not know about Ms. Strong's many other important roles as an advocate for fertility awareness, as a pioneer in developing fertility yoga programs and as a wife and mother whose journey to conceive her second child transformed her life.

4 Jan 2011

New options in fertility preservation for oncology patients

Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.

4 Jan 2011

New women’s health policy inadequate

The Gillard government is being criticized for issuing a women’s health policy without announcing more funding for struggling women’s services. This is the first national women’s health policy in 21 years that claims to ensure women “have access to the right healthcare at the right time”.

30 Dec 2010

Infertility News and Research

Further Reading

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

First Edition: January 25, 2011

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Lifetime tool for families created through sperm donation

Vitrolife receives patent protection for Swemed Sense needle in European markets

Living at higher altitudes may increase risk for suicide

BPA more harmful to women with hormonal and fertility imbalances

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

CE mark approves Vitrolife's SpermFreeze Solution

How chlamydia increases risk of ectopic pregnancy

Proposed health research agency for UK

Shady Grove Fertility and Cade Foundation grant help paralyzed patient and wife deliver healthy baby boy

Researchers identify gene mutation for that is essential for correct protein-processing in cells

Hologic announces acquisition of Interlace Medical

Study compares treatment cost of PID hospitalizations, ER care for teen girls

The Surrogacy Lawyer discusses role of yoga in helping women cope with infertility

New options in fertility preservation for oncology patients

New women’s health policy inadequate

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News